McLaren Greater Lansing — Lansing, Michigan

McLaren Greater Lansing is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

McLaren Greater Lansing has participated in 28 clinical trials with 13 currently active.

Therapeutic areas: Coronary Artery Disease, Ductal Breast Carcinoma, Invasive Breast Carcinoma.

Sponsors: Shanghai MicroPort Medical (Group) Co., Ltd., Alliance for Clinical Trials in Oncology, Renibus Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lansing

Browse all research sites in Michigan · View every site in Lansing

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for McLaren Greater Lansing?

McLaren Greater Lansing has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has McLaren Greater Lansing conducted?

McLaren Greater Lansing has 28 clinical trials on record, with 13 currently active. Their work covers Coronary Artery Disease, Ductal Breast Carcinoma, Invasive Breast Carcinoma.

Is McLaren Greater Lansing accredited by Crixeo Clinical Trials?

McLaren Greater Lansing has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about McLaren Greater Lansing?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.